ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Adiponectin and metabolic syndrome
Author(s): Matsuzawa Y, Funahashi T, Kihara S, Shimomura I
Source: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY    Volume: 24    Issue: 1    Pages: 29-33    Published: JAN 2004  
Times Cited: 345     References: 36     
Abstract: In this review article, the crucial roles of adipocytes in the development of so-called metabolic syndrome and vascular disease are reviewed, focusing on adipocyte-derived bioactive substances, adipocytokines. Recent progress in adipocyte biology shows that adipocytes are not merely energy-storing cells but that they secrete a variety of hormones cytokines, growth factors, and other bioactive substances. To search for novel adipocytokines by the large-scale random sequence analysis of expressed genes in adipocytes, we identified an adipose-specific collagen-like molecule, adiponectin. This novel adipocytokine has plural biofunctions, such as antidiabetic, antiatherosclerotic, and antiinflammatory functions. Adiponectin plasma levels decrease with the accumulation of visceral adipose tissue. In this review, we discuss the link of adiponectin to visceral adiposity, insulin resistance, and vascular diseases.
Document Type: Review
Language: English
Reprint Address: Matsuzawa, Y (reprint author), Osaka Univ, Grad Sch, Sumitomo Hosp, Kita Ku, 5-3-20 Nakanoshima, Osaka 5300005, Japan
Addresses:
1. Osaka Univ, Grad Sch, Sumitomo Hosp, Dept Internal Med & Mol Sci, Osaka 5300005, Japan
Publisher: LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
Subject Category: Hematology; Peripheral Vascular Disease
IDS Number: 760BV
ISSN: 1079-5642
DOI: 10.1161/01.ATV.0000099786.99623.EF
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo